We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$4.92B
AUM Growth
+$1.62B
Cap. Flow
+$1.41B
Cap. Flow %
28.67%
Top 10 Hldgs %
36.75%
Holding
1,419
New
468
Increased
176
Reduced
163
Closed
410

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$208M
2
AMZN icon
Amazon
AMZN
+$165M
3
AMD icon
Advanced Micro Devices
AMD
+$86.9M
4
XYZ
Block Inc
XYZ
+$33.2M
5
ROKU icon
Roku
ROKU
+$27M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$10.3M
2
MRNA icon
Moderna
MRNA
+$9.79M
3
JD icon
JD.com
JD
+$6.14M
4
AZN icon
AstraZeneca
AZN
+$5.27M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.32M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.5%
2 Technology 4.33%
3 Communication Services 2.49%
4 Healthcare 1.87%
5 Financials 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDD icon
601
CALL
Pinduoduo
PDD
$126B
$583K 0.01%
10,000
CS
602
PUT
DELISTED
Credit Suisse Group
CS
$578K 0.01%
60,000
VOD icon
603
CALL
Vodafone
VOD
$37.1B
$572K 0.01%
+38,300
New +$584K
DOW icon
604
CALL
Dow Inc
DOW
$22B
$567K 0.01%
10,000
XPOA
605
CALL
DELISTED
DPCM Capital, Inc.
XPOA
$557K 0.01%
+56,700
New +$557K
FFAI
606
PUT
Faraday Future Intelligent Electric
FFAI
$11.8M
0
HPP
607
Hudson Pacific Properties
HPP
$758M
$550K 0.01%
+3,182
New +$580K
PII icon
608
CALL
Polaris
PII
$3.83B
$550K 0.01%
+5,000
New +$589K
NEWR
609
DELISTED
New Relic, Inc.
NEWR
$550K 0.01%
+5,000
New +$482K
BE icon
610
PUT
Bloom Energy
BE
$48.2B
$548K 0.01%
25,000
SIRI icon
611
CALL
SiriusXM
SIRI
$11B
$547K 0.01%
8,610
PETQ
612
CALL
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$534K 0.01%
23,500
EQT icon
613
CALL
EQT Corp
EQT
$32.9B
$523K 0.01%
24,000
ACIW icon
614
ACI Worldwide
ACIW
$6.12B
$521K 0.01%
+15,000
New +$481K
PENN icon
615
PENN Entertainment
PENN
$2.84B
$519K 0.01%
10,000
-4,500
-31% -$273K
BMY icon
616
CALL
Bristol-Myers Squibb
BMY
$129B
$511K 0.01%
8,200
ESTA icon
617
CALL
Establishment Labs
ESTA
$2.71B
$507K 0.01%
+7,500
New +$524K
PDD icon
618
Pinduoduo
PDD
$126B
$507K 0.01%
+8,700
New +$686K
PDD icon
619
PUT
Pinduoduo
PDD
$126B
$507K 0.01%
8,700
-26,300
-75% -$2.07M
JAZZ icon
620
Jazz Pharmaceuticals
JAZZ
$16.1B
$506K 0.01%
+3,975
New +$522K
EDIT icon
621
Editas Medicine
EDIT
$399M
$505K 0.01%
19,025
-63,475
-77% -$2.18M
VRAY
622
DELISTED
ViewRay, Inc.
VRAY
$505K 0.01%
91,604
+38,604
+73% +$235K
RETA
623
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$501K 0.01%
+19,000
New +$1.47M
GLNG icon
624
CALL
Golar LNG
GLNG
$4.82B
$496K 0.01%
+40,000
New +$510K
BNY
625
Bank of New York Mellon
BNY
$103B
$494K 0.01%
8,500
+3,500
+70% +$201K

Similar funds

SG3 Management's Q4 2021 Portfolio in Review

As of Q4 2021, SG3 Management held 1,419 positions worth $4.92B, up 49% from $3.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

SG3 Management deployed $1.41B of net new capital in Q4 2021, opening 468 new positions and adding to 176 existing holdings. Its largest new stake was Tesla: 619,500 shares worth $218M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 0.74% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Moderna, an estimated $9.79M trimmed.

  • SG3 Management's largest Q4 2021 buy was Tesla: 619,500 shares worth $218M.
  • SG3 Management added most to Amazon in Q4 2021, an estimated $165M increase.
  • SG3 Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $9.79M.
  • SG3 Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $10.3M.
  • SG3 Management's ten largest holdings make up 37% of its $4.92B portfolio in Q4 2021.
  • SG3 Management opened 468 new positions and closed 410 in Q4 2021.
  • SG3 Management's portfolio value rose 49% quarter-over-quarter to $4.92B.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.